Tranzyme Pharma Announces Resignation of Chief Financial Officer

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2012 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM), today announced that Richard I. Eisenstadt, Vice President, Finance and Chief Financial Officer, has resigned … more

View todays social media effects on OCRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Ocera is hiring next, click here to view